Research graph
References from Rezvilutamide versus bicalutamide with androgen-deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer: a multicenter retrospective cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
